Estonia Pharmaceutical Licensing

Estonia has a national system; no separate federal or state/provincial pharmaceutical licensing authorities were identified. SAM lists pharmacy services, wholesale distribution and manufacturing as separate licences; one entity may have multiple locations, but each location must be licensed separately.

A licence applies only to the activities, locations and special conditions stated in it. It does not automatically cover product marketing, personnel registration, controlled drugs, imports from third countries or general corporate matters. The retail, wholesale and manufacturing pages set out entity-related and cross-licensing rules. These should be checked individually against the actual applicant and current law, and should not be generalised as universal foreign-ownership or company-form requirements.

— Retail: pharmacy services licence.

— Wholesale: WDA, excluding transactions with patients.

— Manufacturing: MIA and applicable import release.

SAM is responsible for activity licences for the handling of medicinal products, marketing authorisations, supervision of cross-border movement and oversight of persons handling medicinal products. The primary legal basis is the Medicinal Products Act; procedures are also governed by the general part of the Economic Activities Code Act and relevant regulations.

The Health Board handles the individual registration of pharmacists and assistant pharmacists. Business licences and individual registration do not replace one another.

— SAM: businesses, locations, products and cross-border oversight.

— Health Board: individual professional registration.

— Riigi Teataja: official legal database.

Retail dispensing of medicinal products requires an application for a pharmacy services activity licence. General pharmacies, hospital pharmacies and veterinary pharmacies are distinct categories; hospital pharmacies primarily supply their affiliated hospitals and do not sell medicines directly to the public.

Distance sales may be applied for under an existing licence only by a licensed general or veterinary pharmacy. Prescription medicines must use the Estonian Prescription Centre's e-prescription system and undergo secure identity verification; narcotic drugs, psychotropic drugs and other such products may not be sold online.

— Branch pharmacies must be licensed separately.

— Pharmacies must procure from authorised suppliers.

— Pharmacies must accept expired or unused medicines and arrange their disposal.

Wholesale is trade between businesses or institutions and excludes transactions with patients. The wholesale licence holder is responsible for its transport arrangements, even when transport is performed by a service provider. Supplies may be made to pharmacies, qualified wholesalers, manufacturers and other legally authorised recipients.

SAM conducts inspections against GDP before issuing a licence and on an ongoing basis. Its public page states that a GDP certificate is generally valid for five years, while an activity licence generally has no fixed term; these should be managed separately.

— Hold a WDA and comply with GDP.

— Appoint a responsible wholesale person.

— Supply only legally qualified recipients.

Packaging, repackaging, labelling, relabelling, quality control and batch release may constitute manufacturing and should not be treated simply as ordinary warehousing or wholesaling. The manufacturing licence holder is responsible for applicable GMP, the quality system and product release.

Statutory exceptions apply to dispensing by pharmacies against prescriptions, preparation in accordance with statutory formulas, or retail repackaging, as well as to certain packaging or labelling of investigational medicinal products for the hospital pharmacy's own hospital. These exceptions must not be extended into a general manufacturing exemption.

— Active substances and certain herbal substances may fall within the scope of manufacturing.

— Wholesale of medicines not manufactured by the manufacturer requires separate consideration of a WDA.

— The scope is governed by the special conditions of the licence.

Pharmacy services are provided by pharmacists and assistant pharmacists; wholesale requires a responsible person; and manufacturing applications must provide details of responsible persons. Roles and responsibilities should correspond to the actual licensed scope and quality responsibilities.

Pharmacists or assistant pharmacists qualified abroad who intend to work in Estonia must register with the Health Board. Its page lists credential assessment, proof of identity, qualifications, relevant work experience where required, and fees; the authority decides whether additional documents or a competency examination are required in an individual case.

— Keep records of personnel qualifications, registration, appointments and training.

— Changes to responsible persons are subject to notification or amendment rules.

— An activity licence does not automatically recognise individual qualifications.

The application must describe the right to use the premises, layout, equipment, storage and quality control; wholesale and manufacturing also involve transport. SAM may verify the premises, activities and, where necessary, personnel, usually by inspecting the business location.

Manufacturing also involves processes, equipment, maintenance, validation and calibration, contract work, batch release, personnel/material flows, ventilation and water systems. Public sources do not specify a uniform floor-area requirement applicable to all categories; this record sets no area threshold.

— Pharmacy: layout, equipment, storage and branch information.

— Wholesale: storage and transport, organisational arrangements and qualified warehousing.

— Manufacturing: GMP-related quality and environmental information.

Apply to SAM for a new licence or a variation. Applications may be submitted through the customer portal, by email or by post; forms are available only in Estonian. Applications must be signed by the applicant’s authorised representative and the person in charge of the site, and the fee must be paid in advance.

General documentation includes the application form, proof of payment, and premises, equipment, storage and quality information. Retail applications also require information about the person in charge; wholesale applications require transport and organisational information; and manufacturing applications require process and quality-system information. If the documentation is incomplete, SAM may request further information or corrective action.

— Determine the location, scope and any special conditions.

— Prepare personnel and quality-system information according to the activity.

— Keep records of submissions and responses to requests for further information.

SAM generally makes a decision within 60 days of receiving all documents. Requests for further documents, explanations or corrective action extend the processing period; official guidance states that it may be extended by up to 30 days. Activity licences are generally issued without a fixed term, unless the applicant requests a specific term.

Published new-licence fees are: pharmacy without dispensing rights, 500 euros; pharmacy with dispensing rights, 1,000 euros; wholesale, 2,000 euros; and manufacturing, 500, 2,000 or 2,500 euros depending on category. Pay before submission and verify the amounts against the official page on the day of application.

— Pharmacy distance-selling rights: 500 euros.

— Partial wholesale variations: 500 or 1,000 euros.

— Partial manufacturing variations: the page lists fees from 150 to 1,000 euros, depending on category.

Licence holders must operate in accordance with the activities, locations and conditions specified in their licences. Wholesale operations must continuously comply with GDP, and manufacturing operations with GMP. SAM may conduct inspections before licensing, routinely, following a change or for cause.

Suspension or termination must be notified to SAM in writing at least 30 days in advance. A licence may be revoked if a retail or wholesale business does not commence within 12 months after the licence is issued or ceases operations for 12 consecutive months; for manufacturing, the corresponding periods are 24 months without commencement or a continuous cessation of 24 months. Serious breaches of licence conditions may also result in revocation.

— Maintain compliance of personnel, premises, storage and transport, and quality systems.

— GDP inspections of wholesalers may be adjusted according to risk.

— Licensed wholesalers/manufacturers handling controlled drugs must submit quarterly reports.

Changes to the location, structural unit, special conditions or contract-manufacturing company must be applied for in advance from SAM as a licence variation, with the applicable fee paid. Other changes to information forming the basis of the licence must be notified to SAM in writing as soon as possible, usually no later than seven days. The departure of the person in charge and arrangements for a replacement must be reported immediately.

If a subsequent change requires the licence details to be amended, an application for a variation must be submitted within two months at the latest. Ordinary variations are decided within 30 days; in special circumstances, this may be extended to 60 days. The wholesale page recommends submitting the application at least 30 days before the change takes effect.

— Assess changes to location, scope, person in charge, warehousing and contractors.

— Consult SAM in advance if a transaction affects the legal entity or the basis on which the licence was issued.

Transfer of a product marketing authorisation is a separate product procedure.

As a rule, medicines for sale or use must have a marketing authorisation issued by SAM or the European Commission, or a one-off import and sale authorisation issued by SAM. Scientific assessment of a marketing authorisation and a company’s activity licence are two separate regulatory systems.

As a rule, direct import from a third country and release in Estonia are limited to holders of a manufacturing activity licence, and also require an import authorisation from SAM. Medicines without an Estonian marketing authorisation additionally require the relevant licence holder and special conditions; goods requiring special authorisation must be applied for shipment by shipment.

Narcotic drugs, psychotropic substances and medicines containing such substances are subject to separate special conditions, requirements for a person in charge, storage, records, quarterly reporting and cross-border authorisations. Wholesale or manufacturing licences must specify the relevant special conditions; online pharmacies may not sell them.

— Obtain and maintain marketing authorisations and activity licences separately.

— Third-country imports: manufacturing licence plus import authorisation.

— Cross-border movements of controlled drugs: special authorisation for each shipment.